Ver mas grande
APP antibody
FT-FNab00513
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC |
| Target | APP |
| Research Area | Neuroscience, Signal Transduction, Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | monoclonal |
| Immunogen | amyloid beta A4 precursor protein |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Amyloid-beta precursor protein (APP)|ABPP|APPI|Alzheimer disease amyloid A4 protein homolog|Alzheimer disease amyloid protein|Amyloid precursor protein|Amyloid-beta (A4) precursor protein|Amyloid-beta A4 protein|Cerebral vascular amyloid peptide (CVAP)|Pr |
| Host | Mouse |
| UniProt ID | P05067 |
| Gene ID | 351 |
| Purification | Protein A+G purification |
| Clone Number | 8B9 |
| Iso type | IgG2a |
| Reactivity | Human, Pig |
| Observed MW | 100 kDa |
| Background | Beta-amyloid peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Beta-amyloid 42 is a more effective reductant |
Más información
APP antibody